Short interest in Fate Therapeutics Inc (NASDAQ:FATE) increased during the last reporting period, rising from 10.39M to 11.35M. This put 11.43% of the company's publicly available shares short.

Short interest for Fate Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Fate Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 6.84M shares traded per day, it would take 1.66 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.